BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang R, Chen H, Yan W, Zheng M, Zhang T, Zhang Y. Ferrocene-containing hybrids as potential anticancer agents: Current developments, mechanisms of action and structure-activity relationships. Eur J Med Chem 2020;190:112109. [PMID: 32032851 DOI: 10.1016/j.ejmech.2020.112109] [Cited by in Crossref: 71] [Cited by in F6Publishing: 77] [Article Influence: 23.7] [Reference Citation Analysis]
Number Citing Articles
1 Koszytkowska-Stawińska M, Buchowicz W. Ferrocene-triazole conjugates: do we know why they are biologically active? Dalton Trans 2023;52:1501-17. [PMID: 36651023 DOI: 10.1039/d2dt03161b] [Reference Citation Analysis]
2 López-Hernández JE, Contel M. Promising heterometallic compounds as anticancer agents: Recent studies in vivo. Curr Opin Chem Biol 2023;72:102250. [PMID: 36566618 DOI: 10.1016/j.cbpa.2022.102250] [Reference Citation Analysis]
3 Lorca M, Cabezas D, Araque I, Terán A, Hernández S, Mellado M, Espinoza L, Mella J. Cancer and brassinosteroids: Mechanisms of action, SAR and future perspectives. Steroids 2023;190:109153. [PMID: 36481216 DOI: 10.1016/j.steroids.2022.109153] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Yan J, Yue K, Fan X, Xu X, Wang J, Qin M, Zhang Q, Hou X, Li X, Wang Y. Synthesis and bioactivity evaluation of ferrocene-based hydroxamic acids as selective histone deacetylase 6 inhibitors. Eur J Med Chem 2023;246:115004. [PMID: 36516583 DOI: 10.1016/j.ejmech.2022.115004] [Reference Citation Analysis]
5 Al-ejli MO, Eribi A, Alahzm AM, Salih KS. Synthesis, structural elucidation and optical activity of symmetric Schiff base-functionalized ferrocenes: Synergetic experimental and DFT insights. Journal of Molecular Structure 2023. [DOI: 10.1016/j.molstruc.2023.135052] [Reference Citation Analysis]
6 Bansode P, Pore D, Tayade S, Patil S, Choudhari P, Rashinkar G. Remarkable anticancer activity and molecular docking studies of ferrocene tethered pyrimidobenzothiazoles and pyrimidobenzimidazoles. Results in Chemistry 2022. [DOI: 10.1016/j.rechem.2022.100758] [Reference Citation Analysis]
7 Ling YY, Wang WJ, Hao L, Wu XW, Liang JH, Zhang H, Mao ZW, Tan CP. Self-Amplifying Iridium(III) Photosensitizer for Ferroptosis-Mediated Immunotherapy Against Transferrin Receptor-Overexpressing Cancer. Small 2022;18:e2203659. [PMID: 36310137 DOI: 10.1002/smll.202203659] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Sharifi S, Wahid Mesbah A, Iravani E. A new unsymmetrical ferrocene-based double azine as a multichannel chemosensor for the detection of Cu2+ ions. Results in Chemistry 2022. [DOI: 10.1016/j.rechem.2022.100747] [Reference Citation Analysis]
9 Ramos-inza S, Plano D, Sanmartín C. Metal-based compounds containing selenium: An appealing approach towards novel therapeutic drugs with anticancer and antimicrobial effects. European Journal of Medicinal Chemistry 2022;244:114834. [DOI: 10.1016/j.ejmech.2022.114834] [Reference Citation Analysis]
10 Snegur LV. Modern Trends in Bio-Organometallic Ferrocene Chemistry. Inorganics 2022;10:226. [DOI: 10.3390/inorganics10120226] [Reference Citation Analysis]
11 Mohagheghpour E, Farzin L, Malek M, Sadjadi S. A sensing strategy based on aptamers alkylated with melphalan and graphite nanocrystals in a bed of tetrahedral amorphous carbon for electrochemical detection of lead ions in human urine. Microchemical Journal 2022. [DOI: 10.1016/j.microc.2022.108206] [Reference Citation Analysis]
12 dos Santos Filho JM, de Souza Castro MVB. Synthesis, structural characterization, and antimicrobial activity of novel ferrocene-N-acyl hydrazones designed by means of molecular simplification strategy Celebrating the 100th anniversary of the birth of Professor Paulo Freire. Journal of Organometallic Chemistry 2022;979:122488. [DOI: 10.1016/j.jorganchem.2022.122488] [Reference Citation Analysis]
13 Tang W, Gao Y, Tong H, Xu X, Zhu Z, Liu B, Liu B. Green synthesis of ferrocenyl chalcones against triple negative breast cancer.. [DOI: 10.21203/rs.3.rs-2145219/v1] [Reference Citation Analysis]
14 Jogpethe A, Jadav T, Rajput N, Kumar Sahu A, Das R, Gupta A, Shard A, Sengupta P. LC/Q-TOF MS and LC/QQQ MS based bioanalysis of a new ferrocene derivative as a potential anticancer lead with promising drug-like characteristics. J Chromatogr B Analyt Technol Biomed Life Sci 2022;1210:123469. [PMID: 36137491 DOI: 10.1016/j.jchromb.2022.123469] [Reference Citation Analysis]
15 Poje G, Marinović M, Pavić K, Mioč M, Kralj M, de Carvalho LP, Held J, Perković I, Rajić Z. Harmicens, Novel Harmine and Ferrocene Hybrids: Design, Synthesis and Biological Activity. Int J Mol Sci 2022;23. [PMID: 36012590 DOI: 10.3390/ijms23169315] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ranjan A, Sharma D, Srivastava AK, Varma A, Magani SK, Joshi RK. Evaluation of anticancer activity of ferrocene based benzothiazole and β-ketooxothioacetal. Journal of Organometallic Chemistry 2022. [DOI: 10.1016/j.jorganchem.2022.122500] [Reference Citation Analysis]
17 Gupta A, Das R, Chamoli A, Choithramani A, Kumar H, Patel S, Khude D, Bothra G, Wangdale K, Ghosh Chowdhury M, Rathod R, Mandoli A, Shard A. A Series of Ferrocene-Containing Pyrazolo[1,5- a ]pyrimidines Induce a Strong Antiproliferative Effect against Oral Cancer Cells. Organometallics. [DOI: 10.1021/acs.organomet.2c00348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Estrada-osorio D, Escalona-villalpando RA, Gutiérrez A, Arriaga L, Ledesma-garcía J. Poly-L-lysine-modified with ferrocene to obtain a redox polymer for mediated glucose biosensor application. Bioelectrochemistry 2022;146:108147. [DOI: 10.1016/j.bioelechem.2022.108147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Pigeon P, Gaschard M, Othman M, Salmain M, Jaouen G. α-Hydroxylactams as Efficient Entries to Diversely Functionalized Ferrociphenols: Synthesis and Antiproliferative Activity Studies. Molecules 2022;27:4549. [PMID: 35889422 DOI: 10.3390/molecules27144549] [Reference Citation Analysis]
20 Baryshnikova SV, Poddel'sky AI. Heteroligand Metal Complexes with Extended Redox Properties Based on Redox-Active Chelating Ligands of o-Quinone Type and Ferrocene. Molecules 2022;27:3928. [PMID: 35745052 DOI: 10.3390/molecules27123928] [Reference Citation Analysis]
21 Jiang T, Cao YN, Xu JB, Gao F, Zheng LL. Molecular-docking-guided design, palladium-catalyzed synthesis and anticancer activity of paclitaxel-benzoxazoles hybrids. Sci Rep 2022;12:10021. [PMID: 35705688 DOI: 10.1038/s41598-022-14172-3] [Reference Citation Analysis]
22 Rahimpour S, Luo L, Teimuri-mofrad R. Preparation of ferrocenyl-furan modified graphene oxide via Diels-Alder click reaction and using of its polypyrrole nanocomposites as supercapacitor electrode material. Electrochimica Acta 2022;416:140285. [DOI: 10.1016/j.electacta.2022.140285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Mazzeo G, Pedotti S, Longhi G, Patti A, Abbate S. Spectroscopic investigation on 1,2-substituted ferrocenes with only planar chirality: How chiroptical data are related to absolute configuration and to substituents. Spectrochim Acta A Mol Biomol Spectrosc 2022;272:121010. [PMID: 35180485 DOI: 10.1016/j.saa.2022.121010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Zhang S, Yi C, Li WW, Luo Y, Wu YZ, Ling HB. The current scenario on anticancer activity of artemisinin metal complexes, hybrids, and dimers. Arch Pharm (Weinheim) 2022;:e2200086. [PMID: 35484335 DOI: 10.1002/ardp.202200086] [Reference Citation Analysis]
25 Jadhav J, Das R, Kamble S, Chowdhury MG, Kapoor S, Gupta A, Vyas H, Shard A. Ferrocene-Based Modulators of Cancer-Associated Tumor Pyruvate Kinase M2. Journal of Organometallic Chemistry 2022. [DOI: 10.1016/j.jorganchem.2022.122338] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
26 Zhang J, Gao F, Qi L, Yin X. The crystal structure of ( E )-1-ferrocenyl-3-(naphthalen-1-yl)prop-2-en-1-one, C 23 H 18 FeO. Zeitschrift für Kristallographie - New Crystal Structures 2022;0. [DOI: 10.1515/ncrs-2022-0058] [Reference Citation Analysis]
27 Wang Y, Pigeon P, Li W, Yan J, Dansette PM, Othman M, Mcglinchey MJ, Jaouen G. Diversity-oriented synthesis and bioactivity evaluation of N-substituted ferrocifen compounds as novel antiproliferative agents against TNBC cancer cells. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114202] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Rodionov AN, Korlyukov AA, Simenel AA. Synthesis, structure of 5,7-dimethyl-3-ferrocenyl-2,3-dihydro-1H-pyrazolo- [1,2-a]-pyrazol-4-ium tetrafluoroborate. DFTB calculations of interaction with DNA. Journal of Molecular Structure 2022;1251:132070. [DOI: 10.1016/j.molstruc.2021.132070] [Reference Citation Analysis]
29 Shuvalov VY, Rozhkova YS, Plekhanova IV, Kostyuchenko AS, Shklyaev YV, Fisyuk AS. Synthesis of 3-Amino-6,7-Dihydroferroceno[a]Quinolizin-4-One Derivatives via the Reaction of 3,4-Dihydroferroceno[c]Pyridines with Azlactones. Chem Heterocycl Comp. [DOI: 10.1007/s10593-022-03050-5] [Reference Citation Analysis]
30 Anusionwu CG, Aderibigbe BA, Adeyemi SA, Ubanako P, Oselusi SO, Choonara YE, Mbianda XY. NOVEL FERROCENYLBISPHOSPHONATE HYBRID COMPOUNDS: SYNTHESIS, CHARACTERIZATION AND POTENT ACTIVITY AGAINST CANCER CELL LINES. Bioorganic & Medicinal Chemistry 2022. [DOI: 10.1016/j.bmc.2022.116652] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Paprocka R, Wiese-szadkowska M, Janciauskiene S, Kosmalski T, Kulik M, Helmin-basa A. Latest developments in metal complexes as anticancer agents. Coordination Chemistry Reviews 2022;452:214307. [DOI: 10.1016/j.ccr.2021.214307] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 25.0] [Reference Citation Analysis]
32 Valdés H, Germán-Acacio JM, van Koten G, Morales-Morales D. Bimetallic complexes that merge metallocene and pincer-metal building blocks: synthesis, stereochemistry and catalytic reactivity. Dalton Trans 2022;51:1724-44. [PMID: 34985477 DOI: 10.1039/d1dt03870b] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
33 Jakopec S, Pantalon Juraj N, Brozovic A, Jadreško D, Perić B, Kirin SI, Raić‐malić S. Ferrocene conjugates linked by 1,2,3‐triazole and their Zn(II) and Cu(II) complexes: Synthesis, characterization and biological activity. Applied Organom Chemis. [DOI: 10.1002/aoc.6575] [Reference Citation Analysis]
34 Cheng Y, Ji Y, Ouyang D. FC-BBR/IND-induced glucose oxidase nanodrugs for targeted combination therapy. Int J Pharm 2022;611:121349. [PMID: 34871713 DOI: 10.1016/j.ijpharm.2021.121349] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Casado CM, Alonso B, García-armada MP. Ferrocenes and Other Sandwich Complexes of Iron. Comprehensive Organometallic Chemistry IV 2022. [DOI: 10.1016/b978-0-12-820206-7.00083-4] [Reference Citation Analysis]
36 Mbaba M, Khanye SD, Smith GS, Biot C. Organometallic Chemistry of Drugs Based on Iron. Comprehensive Organometallic Chemistry IV 2022. [DOI: 10.1016/b978-0-12-820206-7.00046-9] [Reference Citation Analysis]
37 Schoch S, Braccini S, Biancalana L, Pratesi A, Funaioli T, Zacchini S, Pampaloni G, Chiellini F, Marchetti F. When ferrocene and diiron organometallics meet: triiron vinyliminium complexes exhibit strong cytotoxicity and cancer cell selectivity. Inorg Chem Front . [DOI: 10.1039/d2qi00534d] [Reference Citation Analysis]
38 Li Z, Lu Y, Zeng Q, Liu Y, Chen A, Guan J, Wang H, Wang J, Wang Z, Zhang L. A new covalently linked ferrocene-containing organosulfur cathode material for high stability lithium–sulfur batteries. J Mater Chem A 2022. [DOI: 10.1039/d2ta06807a] [Reference Citation Analysis]
39 Pereira D, Pinto M, Correia-da-Silva M, Cidade H. Recent Advances in Bioactive Flavonoid Hybrids Linked by 1,2,3-Triazole Ring Obtained by Click Chemistry. Molecules 2021;27:230. [PMID: 35011463 DOI: 10.3390/molecules27010230] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
40 Yang Z, Zhou Z, Luo X, Luo X, Luo H, Luo L, Yang W. Design and Synthesis of Novel Podophyllotoxins Hybrids and the Effects of Different Functional Groups on Cytotoxicity. Molecules 2021;27:220. [PMID: 35011453 DOI: 10.3390/molecules27010220] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Jamali H, Teimuri‐mofrad R. Synthesis of ferrocene‐based esters by alkylation of carboxylate ions and investigation of their electrochemical and optical behaviors. Applied Organom Chemis. [DOI: 10.1002/aoc.6545] [Reference Citation Analysis]
42 Lou H, Fang H, Wang T, Wang D, Han Q, Zhou W, Song Y, Tan W, Zhou B. Biodegradable Porous Polymeric Drug with pH-Stimuli-Responsive Delivery Capacity for Combined Cancer Therapy. ACS Appl Polym Mater 2022;4:714-24. [DOI: 10.1021/acsapm.1c01502] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
43 Kovačević M, Čakić Semenčić M, Radošević K, Molčanov K, Roca S, Šimunović L, Kodrin I, Barišić L. Conformational Preferences and Antiproliferative Activity of Peptidomimetics Containing Methyl 1'-Aminoferrocene-1-carboxylate and Turn-Forming Homo- and Heterochiral Pro-Ala Motifs. Int J Mol Sci 2021;22:13532. [PMID: 34948332 DOI: 10.3390/ijms222413532] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Johnson AD, Buhagiar JA, Magri DC. 4-Amino-1,8-naphthalimide-ferrocene conjugates as potential multi-targeted anticancer and fluorescent cellular imaging agents. RSC Med Chem 2021;12:2060-4. [PMID: 35028564 DOI: 10.1039/d1md00246e] [Reference Citation Analysis]
45 Chaudhary A, Poonia K. The redox mechanism of ferrocene and its phytochemical and biochemical compounds in anticancer therapy: A mini review. Inorganic Chemistry Communications 2021;134:109044. [DOI: 10.1016/j.inoche.2021.109044] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
46 Wieczorek-błauż A, Błauż A, Rychlik B, Plażuk D. The synthesis and biological activity of the 3-ferrocenylpropenamides derived from 5(4H)-oxazolones. Journal of Organometallic Chemistry 2021;953:122026. [DOI: 10.1016/j.jorganchem.2021.122026] [Reference Citation Analysis]
47 Sokol I, Toma M, Krnić M, Macan AM, Drenjančević D, Liekens S, Raić-Malić S, Gazivoda Kraljević T. Transition metal-catalyzed synthesis of new 3-substituted coumarin derivatives as antibacterial and cytostatic agents. Future Med Chem 2021;13:1865-84. [PMID: 34533068 DOI: 10.4155/fmc-2021-0161] [Reference Citation Analysis]
48 Sert M, Işılar Ö, Yaglioglu AS, Bulut A. Gabriel-Cromwell aziridination of amino sugars; chiral ferrocenoyl-aziridinyl sugar synthesis and their biological evaluation. Carbohydr Res 2021;509:108430. [PMID: 34488002 DOI: 10.1016/j.carres.2021.108430] [Reference Citation Analysis]
49 Sghyar R, Moussaoui O, Sebbar NK, Ait Elmachkouri Y, Irrou E, Hökelek T, Mague JT, Bentama A, El Hadrami EM. Crystal structure and Hirshfeld surface analysis study of (E)-1-(4-chloro-phen-yl)-N-(4-ferrocenylphen-yl)methanimine. Acta Crystallogr E Crystallogr Commun 2021;77:875-9. [PMID: 34584753 DOI: 10.1107/S2056989021008033] [Reference Citation Analysis]
50 Swarts PJ, Erasmus E, Fourie E. Comparison of synthetic, spectroscopic, computational and electrochemical aspects of ferrocenyl-containing β-diketones, β-ketoesters and β-ketoamides. Polyhedron 2021;205:115279. [DOI: 10.1016/j.poly.2021.115279] [Reference Citation Analysis]
51 Schoch S, Hadiji M, Pereira SAP, Saraiva MLMFS, Braccini S, Chiellini F, Biver T, Zacchini S, Pampaloni G, Dyson PJ, Marchetti F. A Strategy to Conjugate Bioactive Fragments to Cytotoxic Diiron Bis(cyclopentadienyl) Complexes. Organometallics 2021;40:2516-28. [PMID: 34475610 DOI: 10.1021/acs.organomet.1c00270] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
52 Gómez J, Sierra D, Ojeda C, Thavalingam S, Miller R, Guzmán F, Metzler-Nolte N. Solid-phase synthesis and evaluation of linear and cyclic ferrocenoyl/ruthenocenoyl water-soluble hexapeptides as potential antibacterial compounds. J Biol Inorg Chem 2021;26:599-615. [PMID: 34292404 DOI: 10.1007/s00775-021-01877-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Cheng Q, Zhou T, Xia Q, Lu X, Xu H, Hu M, Jing S. Design of ferrocenylseleno-dopamine derivatives to optimize the Fenton-like reaction efficiency and antitumor efficacy. RSC Adv 2021;11:25477-83. [PMID: 35478891 DOI: 10.1039/d1ra03537a] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
54 Biancalana L, De Franco M, Ciancaleoni G, Zacchini S, Pampaloni G, Gandin V, Marchetti F. Easily Available, Amphiphilic Diiron Cyclopentadienyl Complexes Exhibit in Vitro Anticancer Activity in 2D and 3D Human Cancer Cells through Redox Modulation Triggered by CO Release. Chemistry 2021;27:10169-85. [PMID: 34106495 DOI: 10.1002/chem.202101048] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
55 Vecchi A, Sabin JR, Sabuzi F, Conte V, Cicero DO, Floris B, Galloni P, Nemykin VN. Similar, Yet Different: Long-Range Metal-Metal Coupling and Electron-Transfer Processes in Metal-Free 5,10,15,20-Tetra(ruthenocenyl)porphyrin. Inorg Chem 2021;60:8227-41. [PMID: 34033715 DOI: 10.1021/acs.inorgchem.1c00908] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 Campbell E, Hasan MT, Gonzalez-Rodriguez R, Truly T, Lee BH, Green KN, Akkaraju G, Naumov AV. Graphene quantum dot formulation for cancer imaging and redox-based drug delivery. Nanomedicine 2021;:102408. [PMID: 34015513 DOI: 10.1016/j.nano.2021.102408] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
57 Nayeem N, Contel M. Exploring the Potential of Metallodrugs as Chemotherapeutics for Triple Negative Breast Cancer. Chemistry 2021;27:8891-917. [PMID: 33857345 DOI: 10.1002/chem.202100438] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
58 Zheng J, Zeng L, Tang M, Lin H, Pi C, Xu R, Cui X. Novel Ferrocene Derivatives Induce G0/G1 Cell Cycle Arrest and Apoptosis through the Mitochondrial Pathway in Human Hepatocellular Carcinoma. Int J Mol Sci 2021;22:3097. [PMID: 33803555 DOI: 10.3390/ijms22063097] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
59 Ludwig BS, Tomassi S, Di Maro S, Di Leva FS, Benge A, Reichart F, Nieberler M, Kühn FE, Kessler H, Marinelli L, Reuning U, Kossatz S. The organometallic ferrocene exhibits amplified anti-tumor activity by targeted delivery via highly selective ligands to αvβ3, αvβ6, or α5β1 integrins. Biomaterials 2021;271:120754. [PMID: 33756215 DOI: 10.1016/j.biomaterials.2021.120754] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
60 Vessières A, Wang Y, Mcglinchey MJ, Jaouen G. Multifaceted chemical behaviour of metallocene (M = Fe, Os) quinone methides. Their contribution to biology. Coordination Chemistry Reviews 2021;430:213658. [DOI: 10.1016/j.ccr.2020.213658] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
61 Savani CJ, Roy H, Verma SK, Vennapu DR, Singh VK. Synthesis, characterization and evaluation of novel ferrocenylmethylamine derivatives as cytotoxic agents. Appl Organomet Chem 2021;35. [DOI: 10.1002/aoc.6137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
62 Muñoz-osses M, Quiroz J, Vásquez-martínez Y, Flores E, Navarrete E, Godoy F, Torrent C, Cortez-san Martín M, Gómez A, Mascayano C. Evaluation of cyrhetrenyl and ferrocenyl precursors as 5-lipoxygenase inhibitors – biological and computational studies. New J Chem 2021;45:13360-13368. [DOI: 10.1039/d1nj01336j] [Reference Citation Analysis]
63 Kambale V, Jadhav J, Piste P. Ultrasound-assisted, green and efficient synthesis of ferrocene-appended azo-phenothiazines. Current Research in Green and Sustainable Chemistry 2021;4:100125. [DOI: 10.1016/j.crgsc.2021.100125] [Reference Citation Analysis]
64 Shalini, Kumar V. Have molecular hybrids delivered effective anti-cancer treatments and what should future drug discovery focus on? Expert Opin Drug Discov 2021;16:335-63. [PMID: 33305635 DOI: 10.1080/17460441.2021.1850686] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
65 Snegur LV, Borisov YA, Ermolenko YV, Safronova VN, Kiselev SS, Kochetkov KA, Simenel AA. Application of capillary electrophoresis technique for the enantioseparation of bioactive ferrocene-based compounds versus DFT calculated data. Electrophoresis 2020;41:1969-79. [PMID: 32838479 DOI: 10.1002/elps.202000154] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
66 Liu W, Liang Y, Si X. Hydroxamic acid hybrids as the potential anticancer agents: An Overview. European Journal of Medicinal Chemistry 2020;205:112679. [DOI: 10.1016/j.ejmech.2020.112679] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
67 Djaković S, Glavaš‐obrovac L, Lapić J, Maračić S, Kirchofer J, Knežević M, Jukić M, Raić‐malić S. Synthesis and biological evaluations of mono‐ and bis‐ferrocene uracil derivatives. Appl Organomet Chem 2021;35. [DOI: 10.1002/aoc.6052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
68 Xiao J, Gao M, Sun Z, Diao Q, Wang P, Gao F. Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010-2020). Eur J Med Chem 2020;208:112830. [PMID: 32992133 DOI: 10.1016/j.ejmech.2020.112830] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
69 Bouché M, Hognon C, Grandemange S, Monari A, Gros PC. Recent advances in iron-complexes as drug candidates for cancer therapy: reactivity, mechanism of action and metabolites. Dalton Trans 2020;49:11451-66. [PMID: 32776052 DOI: 10.1039/d0dt02135k] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
70 Matiadis D, Sagnou M. Pyrazoline Hybrids as Promising Anticancer Agents: An Up-to-Date Overview. Int J Mol Sci 2020;21:E5507. [PMID: 32752126 DOI: 10.3390/ijms21155507] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 9.7] [Reference Citation Analysis]
71 Ismail MK, Khan Z, Rana M, Horswell SL, Male L, Nguyen HV, Perotti A, Romero-Canelón I, Wilkinson EA, Hodges NJ, Tucker JHR. Effect of Regiochemistry and Methylation on the Anticancer Activity of a Ferrocene-Containing Organometallic Nucleoside Analogue. Chembiochem 2020;21:2487-94. [PMID: 32255248 DOI: 10.1002/cbic.202000124] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
72 Mazur M, Mrozowicz M, Buchowicz W, Koszytkowska-stawińska M, Kamiński R, Ochal Z, Wińska P, Bretner M. Formylation of a metathesis-derived ansa [4]-ferrocene: a simple route to anticancer organometallics. Dalton Trans 2020;49:11504-11. [DOI: 10.1039/d0dt01975e] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]